Guide-yakabatana mibvunzo · Pakati Nhanho
AI muDrug Safety uye Pharmacovigilance Quiz
Ongorora mishumo yakaipa-yechiitiko, kucherechedzwa kwechiratidzo uye yakamisikidzwa kukodha mune zvinodhaka-kuchengetedzwa kwekutarisa mafambiro ekushanda pane zvigadzirwa.
Mubvunzo 1 ye 8
Chii chinangwa chekutanga che pharmacovigilance?
Tarisa mubvunzo wese8 mibvunzo
Mhinduro uye tsananguro zvinoonekwa paunenge uchitora bvunzo.
- Chii chinangwa chekutanga che pharmacovigilance?
- Kuona, kuongorora, nekudzivirira kukuvadzwa kubva kumishonga mushure mekunge yashandiswa
- Kutengesa mishonga mitsva kuvarapi
- Kuisa mutengo wekutengesa wemishonga
- Kugadzira mapiritsi ekurongedza
- In the published n2c2 clinical NLP system, what information did the system extract from narrative notes?
- Only patients’ handwritten signatures
- Medication and adverse-event concepts and their relations
- Only final regulatory decisions
- Only medicine prices
- Chii chinoonesa disproportionality ongororo mumadhatabhesi ezviitiko zvakashata?
- Musiyano wemutengo pakati pema brand negeneric drugs
- Chipatara chipi chakaendesa mishumo yakawanda
- Zviitiko zvezvinodhaka zviviri zvakashumwa kakawanda kupfuura mukana wenhamba ungafanotaura
- Mazuva ekupera kwemishonga
- What is VigiBase, according to Uppsala Monitoring Centre?
- A database of randomized clinical-trial efficacy results only
- A list of confirmed causal side effects for every medicine
- A commercial catalogue of approved drug prices
- The WHO global database of reported adverse events for medicines and vaccines
- Chii chinonzi MedDRA chinoshandiswa mune pharmacovigilance mapaipi?
- Izwi rezvokurapa rakamisikidzwa rekukodha maitiro uye mamiriro
- Mucherechedzo wepakiti yemishonga
- Iyo yekuronga app yevanachiremba
- Mhando yeMRI scanner
- Which sequence does UMC describe in its signal-management process?
- Diagnosis, prescription, dispensing, billing and discharge
- Detection, validation, prioritisation, assessment and communication
- Data collection, automatic causality decision, recall and litigation
- Model training, deployment, billing and marketing
- How should a high disproportionality score in a spontaneous-report database be interpreted?
- As a population incidence rate for all patients
- As a confirmed causal adverse reaction
- As a statistical signal for further assessment, not proof that the drug caused the event
- As proof that no other factor contributed
- Which four elements satisfy the minimum ICSR criteria in ICH E2D(R1)?
- A confirmed causal link, a batch number, a prescriber signature, and a laboratory result
- A product label, a randomized trial, a treatment response, and a safety committee vote
- A hospital admission, a known dose, a genetic profile, and a published case report
- An adverse event or other observation, a suspect or interacting product, an identifiable patient, and an identifiable reporter